{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:37:01Z","timestamp":1791265021841,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":4531,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/mi.2009.89","type":"journal-article","created":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T10:02:58Z","timestamp":1247047378000},"page":"412-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection: an IgA gene and functional analysis"],"prefix":"10.1016","volume":"2","author":[{"given":"D","family":"Tudor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Derrien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Diomede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-S","family":"Drillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Houimel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Moog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-M","family":"Reynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bomsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mi.2009.89_bib1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/nm1197-1250","article-title":"HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals","volume":"3,","author":"Mazzoli","year":"1997","journal-title":"Nat. Med"},{"key":"10.1038\/mi.2009.89_bib2","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1016\/j.vaccine.2007.11.062","article-title":"Not just sheer luck! Immune correlates of protection against HIV-1 infection","volume":"26,","author":"Piacentini","year":"2008","journal-title":"Vaccine"},{"key":"10.1038\/mi.2009.89_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2796.2007.01822.x","article-title":"Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women","volume":"262,","author":"Hirbod","year":"2007","journal-title":"J. Intern. Med"},{"key":"10.1038\/mi.2009.89_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/QAD.0b013e3283196a80","article-title":"The \u201cimmunologic advantage\u201d of HIV-exposed seronegative individuals","volume":"23,","author":"Miyazawa","year":"2009","journal-title":"AIDS"},{"key":"10.1038\/mi.2009.89_bib5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1086\/511988","article-title":"Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals","volume":"195,","author":"Biasin","year":"2007","journal-title":"J. Infect. Dis"},{"key":"10.1038\/mi.2009.89_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.qai.0000222289.97825.35","article-title":"HIV-specific antibodies but not t-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia","volume":"42,","author":"Nguyen","year":"2006","journal-title":"J. Acquir. Immune. Defic. Syndr"},{"key":"10.1038\/mi.2009.89_bib7","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/00002030-200011100-00025","article-title":"Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Cote d'Ivoire","volume":"14,","author":"Ghys","year":"2000","journal-title":"AIDS"},{"key":"10.1038\/mi.2009.89_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1099\/vir.0.80585-0","article-title":"Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin","volume":"86,","author":"Lopalco","year":"2005","journal-title":"J. Gen. Virol"},{"key":"10.1038\/mi.2009.89_bib9","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.4049\/jimmunol.165.9.5170","article-title":"Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells","volume":"165,","author":"Devito","year":"2000","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2009.89_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00042560-200208010-00007","article-title":"Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects","volume":"30,","author":"Devito","year":"2002","journal-title":"J. Acquir. Immune. Defic. Syndr"},{"key":"10.1038\/mi.2009.89_bib11","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.4049\/jimmunol.166.10.6257","article-title":"Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1","volume":"166,","author":"Alfsen","year":"2001","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2009.89_bib12","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/324375","article-title":"Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women","volume":"184,","author":"Belec","year":"2001","journal-title":"J. Infect. Dis"},{"key":"10.1038\/mi.2009.89_bib13","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-200209060-00004","article-title":"Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41","volume":"16,","author":"Clerici","year":"2002","journal-title":"AIDS"},{"key":"10.1038\/mi.2009.89_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/aid.2008.0207","article-title":"Cervical HIV-specific IgA in a population of commercial sex workers correlates with repeated exposure but not resistance to HIV","volume":"25,","author":"Horton","year":"2009","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1038\/mi.2009.89_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00002030-200102160-00026","article-title":"Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection","volume":"15,","author":"Kaul","year":"2001","journal-title":"AIDS"},{"key":"10.1038\/mi.2009.89_bib16","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1128\/JVI.78.19.10724-10737.2004","article-title":"Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope","volume":"78,","author":"Ofek","year":"2004","journal-title":"J. Virol"},{"key":"10.1038\/mi.2009.89_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0952-7915(02)00362-X","article-title":"Neutralizing antibodies against HIV\u2014back in the major leagues?","volume":"14,","author":"Ferrantelli","year":"2002","journal-title":"Curr. Opin. Immunol"},{"key":"10.1038\/mi.2009.89_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/aid.1997.13.1179","article-title":"High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160","volume":"13,","author":"Hocini","year":"1997","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1038\/mi.2009.89_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-7613(00)80610-X","article-title":"Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM","volume":"9,","author":"Bomsel","year":"1998","journal-title":"Immunity"},{"key":"10.1038\/mi.2009.89_bib20","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.4049\/jimmunol.174.8.4828","article-title":"Intraepithelial cell neutralization of HIV-1 replication by IgA","volume":"174,","author":"Huang","year":"2005","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2009.89_bib21","doi-asserted-by":"crossref","first-page":"25649","DOI":"10.1074\/jbc.M200554200","article-title":"HIV-1 gp41 envelope residues 650\u2013685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide","volume":"277,","author":"Alfsen","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1038\/mi.2009.89_bib22","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/JVI.73.3.2469-2480.1999","article-title":"A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity","volume":"73,","author":"Salzwedel","year":"1999","journal-title":"J. Virol"},{"key":"10.1038\/mi.2009.89_bib23","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1073\/pnas.90.7.2700","article-title":"Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor","volume":"90,","author":"Fantini","year":"1993","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1038\/mi.2009.89_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2006.11.035","article-title":"Galactosyl ceramide expressed on dendritic cells can mediate HIV-1 transfer from monocyte derived dendritic cells to autologous T cells","volume":"362,","author":"Magerus-Chatinet","year":"2007","journal-title":"Virology"},{"key":"10.1038\/mi.2009.89_bib25","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1096\/fj.08-113142","article-title":"Both lipid environment and pH are critical for determining physiologic solution structure of 3D-conserved epitopes of the HIV-1 gp41-MPER peptide P1","volume":"22,","author":"Coutant","year":"2008","journal-title":"FASEB J"},{"key":"10.1038\/mi.2009.89_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157016208784324994","article-title":"Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes","volume":"6,","author":"Matoba","year":"2008","journal-title":"Curr. HIV Res"},{"key":"10.1038\/mi.2009.89_bib27","doi-asserted-by":"crossref","first-page":"13584","DOI":"10.1073\/pnas.0405297101","article-title":"A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs","volume":"101,","author":"Matoba","year":"2004","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1038\/mi.2009.89_bib28","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.1128\/JVI.00033-08","article-title":"Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens","volume":"82,","author":"Zhang","year":"2008","journal-title":"J. Virol"},{"key":"10.1038\/mi.2009.89_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/JVI.72.1.286-293.1998","article-title":"Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities","volume":"72,","author":"Alsmadi","year":"1998","journal-title":"J. Virol"},{"key":"10.1038\/mi.2009.89_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1380-2933(97)10004-5","article-title":"A definitive set of oligonucleotide primers for amplifying human V regions","volume":"3,","author":"Sblattero","year":"1998","journal-title":"Immunotechnology"},{"key":"10.1038\/mi.2009.89_bib31","series-title":"Phage Display: A Laboratory Manual","author":"Barbas","year":"2001"},{"key":"10.1038\/mi.2009.89_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4690-3-16","article-title":"Antiviral properties of two trimeric recombinant gp41 proteins","volume":"3,","author":"Delcroix-Genete","year":"2006","journal-title":"Retrovirology"},{"key":"10.1038\/mi.2009.89_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0378-1119(94)90131-7","article-title":"A general vector, pASK84, for cloning, bacterial production, and single-step purification of antibody Fab fragments","volume":"141,","author":"Skerra","year":"1994","journal-title":"Gene"},{"key":"10.1038\/mi.2009.89_bib34","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/01.aids.0000189856.13817.76","article-title":"HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies","volume":"19,","author":"Nakowitsch","year":"2005","journal-title":"AIDS"},{"key":"10.1038\/mi.2009.89_bib35","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1126\/science.1111781","article-title":"Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies","volume":"308,","author":"Haynes","year":"2005","journal-title":"Science"},{"key":"10.1038\/mi.2009.89_bib36","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/QAD.0b013e3282a4a632","article-title":"Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity","volume":"21,","author":"Scherer","year":"2007","journal-title":"AIDS"},{"key":"10.1038\/mi.2009.89_bib37","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1097\/QAD.0b013e328285da15","article-title":"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data","volume":"21,","author":"Vcelar","year":"2007","journal-title":"AIDS"},{"key":"10.1038\/mi.2009.89_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2008.02.007","article-title":"Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination","volume":"375,","author":"Polonis","year":"2008","journal-title":"Virology"},{"key":"10.1038\/mi.2009.89_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-5699(98)01413-3","article-title":"Regional specialisation in the mucosal immune system: what happens in the microcompartments?","volume":"20,","author":"Brandtzaeg","year":"1999","journal-title":"Immnunol. Today"},{"key":"10.1038\/mi.2009.89_bib40","first-page":"103","article-title":"Genetics of immunoglobulins","volume":"58,","author":"Pandey","year":"1993","journal-title":"Immunol. Ser"},{"key":"10.1038\/mi.2009.89_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ng0694-118","article-title":"Unravelling antibody genes","volume":"7,","author":"Zouali","year":"1994","journal-title":"Nat. Genet"},{"key":"10.1038\/mi.2009.89_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1023\/A:1013125726870","article-title":"Molecular determinants of the human antibody response to HIV-1: implications for disease control","volume":"21,","author":"Viau","year":"2001","journal-title":"J. Clin. Immunol"},{"key":"10.1038\/mi.2009.89_bib43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0009-9120(02)00343-0","article-title":"Phage display technology: clinical applications and recent innovations","volume":"35,","author":"Azzazy","year":"2002","journal-title":"Clin. Biochem"},{"key":"10.1038\/mi.2009.89_bib44","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1126\/science.1061692","article-title":"Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design","volume":"293,","author":"Saphire","year":"2001","journal-title":"Science"},{"key":"10.1038\/mi.2009.89_bib45","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/JVI.78.6.3155-3161.2004","article-title":"The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5","volume":"78,","author":"Zwick","year":"2004","journal-title":"J. Virol"},{"key":"10.1038\/mi.2009.89_bib46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1006\/jmbi.1993.1203","article-title":"Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries","volume":"230,","author":"Barbas","year":"1993","journal-title":"J. Mol. Biol"},{"key":"10.1038\/mi.2009.89_bib47","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1006\/jmbi.1998.2396","article-title":"Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire","volume":"285,","author":"de Wildt","year":"1999","journal-title":"J. Mol. Biol"},{"key":"10.1038\/mi.2009.89_bib48","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/QAD.0b013e3282f56b64","article-title":"HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers","volume":"22,","author":"Hirbod","year":"2008","journal-title":"AIDS"},{"key":"10.1038\/mi.2009.89_bib49","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2174\/157016207782418452","article-title":"Neutralizing antibodies in mucosal secretions: IgG or IgA?","volume":"5,","author":"Alexander","year":"2007","journal-title":"Curr. HIV Res"},{"key":"10.1038\/mi.2009.89_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrm1005","article-title":"Entry of viruses through the epithelial barrier: pathogenic trickery","volume":"4,","author":"Alfsen","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1038\/mi.2009.89_bib51","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1172\/JCI115211","article-title":"The polymeric immunoglobulin receptor. A model protein to study transcytosis","volume":"87,","author":"Apodaca","year":"1991","journal-title":"J. Clin. Invest"},{"key":"10.1038\/mi.2009.89_bib52","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1016\/S0264-410X(01)00115-3","article-title":"Immunization of mice with recombinant gp41 in a systemic prime\/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies","volume":"19,","author":"Mantis","year":"2001","journal-title":"Vaccine"},{"key":"10.1038\/mi.2009.89_bib53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.immuni.2004.08.015","article-title":"The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection","volume":"21,","author":"Hovanessian","year":"2004","journal-title":"Immunity"},{"key":"10.1038\/mi.2009.89_bib54","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.4049\/jimmunol.179.5.3144","article-title":"Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12V region","volume":"179,","author":"Mantis","year":"2007","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2009.89_bib55","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1128\/JVI.77.7.4095-4103.2003","article-title":"Characterization of human class-switched polymeric (Immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12","volume":"77,","author":"Wolbank","year":"2003","journal-title":"J. Virol"},{"key":"10.1038\/mi.2009.89_bib56","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jmb.2008.07.057","article-title":"Crystal structure of the complex between the F(ab)\u2032 fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6","volume":"382,","author":"Bryson","year":"2008","journal-title":"J. Mol. Biol"},{"key":"10.1038\/mi.2009.89_bib57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/302575a0","article-title":"Somatic generation of antibody diversity","volume":"302,","author":"Tonegawa","year":"1983","journal-title":"Nature"},{"key":"10.1038\/mi.2009.89_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","article-title":"Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities","volume":"13,","author":"Xu","year":"2000","journal-title":"Immunity"},{"key":"10.1038\/mi.2009.89_bib59","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/jmbi.1997.1442","article-title":"Conformations of the third hypervariable region in the VH domain of immunoglobulins","volume":"275,","author":"Morea","year":"1998","journal-title":"J. Mol. Biol"},{"key":"10.1038\/mi.2009.89_bib60","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.4049\/jimmunol.178.7.4424","article-title":"The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes","volume":"178,","author":"Alam","year":"2007","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2009.89_bib61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nm833","article-title":"Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120","volume":"9,","author":"Veazey","year":"2003","journal-title":"Nat. Med"},{"key":"10.1038\/mi.2009.89_bib62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1566524033479852","article-title":"The role of mucosal immunity in prevention of HIV transmission","volume":"3,","author":"Kozlowski","year":"2003","journal-title":"Curr. Mol. Med"},{"issue":"Suppl 1","key":"10.1038\/mi.2009.89_bib63","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.tube.2007.05.005","article-title":"Progress towards an AIDS mucosal vaccine: an overview","volume":"87","author":"Yuki","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1038\/mi.2009.89_bib64","doi-asserted-by":"crossref","first-page":"9835","DOI":"10.1073\/pnas.0711813105","article-title":"The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics","volume":"105,","author":"Wilson","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1038\/mi.2009.89_bib65","unstructured":"Bomsel, M., Fleury, S. & Zubrigen, R. Virosomes like vesicules comprising GP41 derivate antigen. In PCT\/IB 2006.000466 INSERM\/Mymetics\/Pevion IB 2007\/000466 (2006)."},{"key":"10.1038\/mi.2009.89_bib66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1084\/jem.185.2.293","article-title":"HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women","volume":"185,","author":"Musey","year":"1997","journal-title":"J. Exp. Med"},{"key":"10.1038\/mi.2009.89_bib67","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1073\/pnas.88.18.7978","article-title":"Assembly of combinatorial antibody libraries on phage surfaces: the gene III site","volume":"88,","author":"Barbas","year":"1991","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1038\/mi.2009.89_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/7959","article-title":"Selection of high-affinity phage antibodies from phage display libraries","volume":"17,","author":"de Bruin","year":"1999","journal-title":"Nat. Biotechnol"},{"key":"10.1038\/mi.2009.89_bib69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/prep.1999.1142","article-title":"Use of thiophilic adsorption chromatography for the one-step purification of a bacterially produced antibody F(ab) fragment without the need for an affinity tag","volume":"17,","author":"Fiedler","year":"1999","journal-title":"Protein Expr. Purif"},{"key":"10.1038\/mi.2009.89_bib70","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.4049\/jimmunol.173.10.6274","article-title":"Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages","volume":"173,","author":"Holl","year":"2004","journal-title":"J. Immunol"},{"key":"10.1038\/mi.2009.89_bib71","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/S0264-410X(02)00068-3","article-title":"Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1","volume":"20,","author":"Mascola","year":"2002","journal-title":"Vaccine"},{"key":"10.1038\/mi.2009.89_bib72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/QAD.0b013e328011049b","article-title":"Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells","volume":"21,","author":"Bomsel","year":"2007","journal-title":"AIDS"},{"key":"10.1038\/mi.2009.89_bib73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm0197-42","article-title":"Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier","volume":"3,","author":"Bomsel","year":"1997","journal-title":"Nat. Med"},{"key":"10.1038\/mi.2009.89_bib74","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/QAD.0b013e3282f736f4","article-title":"Early events in HIV transmission through a human vaginal mucosa","volume":"22,","author":"Bouschbacher","year":"2008","journal-title":"AIDS"},{"key":"10.1038\/mi.2009.89_bib75","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/0470090766.ch9","article-title":"IMGT, the international ImMunoGeneTics information system","volume":"254,","author":"Lefranc","year":"2003","journal-title":"Novartis Found Symp"}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mi200989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi200989","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922015628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922015628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi200989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:29:36Z","timestamp":1761830976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021922015628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1933021922015628"],"URL":"https:\/\/doi.org\/10.1038\/mi.2009.89","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection: an IgA gene and functional analysis","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mi.2009.89","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/mi.2009.101","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 \u00a9 Society for Mucosal Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}